We are live on ! Find out more
EGM

Encore Global Management Portfolio holdings

AUM $102M
This Fund
S&P 500
This Quarter Est. Return
+21.92%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$102M
AUM Growth
-$41.4M
Cap. Flow
-$52.7M
Cap. Flow %
-51.72%
Top 10 Hldgs %
40.03%
Holding
74
New
4
Increased
15
Reduced
19
Closed
21

Top Buys

Rank Stock Value
1
REGN icon
Regeneron Pharmaceuticals
REGN
+$2.69M
2
ZTS icon
Zoetis
ZTS
+$2.26M
3
CRSP icon
CRISPR Therapeutics
CRSP
+$1.61M
4
BSX icon
Boston Scientific
BSX
+$1.48M
5
TMO icon
Thermo Fisher Scientific
TMO
+$1.44M

Top Sells

Rank Stock Value
1
VLO icon
Valero Energy
VLO
+$4.89M
2
MRVL icon
Marvell Technology
MRVL
+$4.75M
3
BP icon
BP
BP
+$4.41M
4
JNJ icon
Johnson & Johnson
JNJ
+$4.4M
5
NTRS icon
Northern Trust
NTRS
+$3.36M

Sector Composition

Rank Sector Weight
1 Technology 42.38%
2 Healthcare 17.18%
3 Energy 10.16%
4 Communication Services 10.03%
5 Financials 9.57%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BIIB icon
51
Biogen
BIIB
$32.3B
$108K 0.11%
500
– –
BJ icon
52
BJs Wholesale Club
BJ
$11.4B
$87.2K 0.09%
1,000
-16,000
-94% -$1.46M
MRNA icon
53
Moderna
MRNA
$55.1B
$70K 0.07%
1,000
– –
ABBV icon
54
AbbVie
ABBV
$451B
– –
-2,500
Closed -$544K
BP icon
55
BP
BP
$109B
– –
-93,750
Closed -$4.41M
IBB icon
56
iShares Biotechnology ETF
IBB
$10.5B
– –
-6,000
Closed -$1.01M
IGV icon
57
iShares Expanded Tech-Software Sector ETF
IGV
$15.1B
– –
-24,300
Closed -$1.95M
INTC icon
58
Intel
INTC
$473B
– –
-49,500
Closed -$2.18M
JNJ icon
59
Johnson & Johnson
JNJ
$646B
– –
-18,000
Closed -$4.4M
LOW icon
60
Lowe's Companies
LOW
$117B
– –
-1,000
Closed -$236K
MPC icon
61
Marathon Petroleum
MPC
$104B
– –
-8,750
Closed -$2.14M
MS icon
62
Morgan Stanley
MS
$337B
– –
-4,000
Closed -$658K
NTRS icon
63
Northern Trust
NTRS
$34.2B
– –
-24,075
Closed -$3.36M
OXY icon
64
Occidental Petroleum
OXY
$59.1B
– –
-50,300
Closed -$3.27M
PSX icon
65
Phillips 66
PSX
$97.4B
– –
-11,000
Closed -$2M
VLO icon
66
Valero Energy
VLO
$101B
– –
-19,800
Closed -$4.89M
XBI icon
67
State Street SPDR S&P Biotech ETF
XBI
$11.3B
– –
-10,800
Closed -$1.38M
XLE icon
68
State Street Energy Select Sector SPDR ETF
XLE
$41.2B
– –
-27,400
Closed -$1.68M
XLI icon
69
State Street Industrial Select Sector SPDR ETF
XLI
$32.9B
– –
-3,000
Closed -$485K
XLK icon
70
State Street Technology Select Sector SPDR ETF
XLK
$121B
– –
-20,000
Closed -$2.66M
XLP icon
71
State Street Consumer Staples Select Sector SPDR ETF
XLP
$14.9B
– –
-21,000
Closed -$1.72M
XLV icon
72
State Street Health Care Select Sector SPDR ETF
XLV
$44.5B
– –
-10,000
Closed -$1.47M
XLY icon
73
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
$23.1B
– –
-11,880
Closed -$1.29M
XOP icon
74
State Street SPDR S&P Oil & Gas Exploration & Production ETF
XOP
$3.78B
– –
-15,000
Closed -$2.73M
1 2
3

Similar funds

LWM
Lionsbridge Wealth Management Jacksonville Beach, Florida $102M AUM 28.57% 1-Year Est. Return
PCP
Pantera Capital Partners San Francisco, California $102M AUM 45.76% 1-Year Est. Return
MC
MSD Capital New York $102M AUM 2.45% 1-Year Est. Return
PWM
Partners Wealth Management Carmel By The Sea, California $102M AUM 23.71% 1-Year Est. Return
ECP
Electric Capital Partners Palo Alto, California $102M AUM
EFA
Englebert Financial Advisers Allentown, Pennsylvania $102M AUM
ACMA
Arbor Capital Management (Alaska) Anchorage, Alaska $102M AUM 14.51% 1-Year Est. Return
GHA
Good Harbor Advisors Gloucester, Massachusetts $102M AUM

Encore Global Management's Q2 2026 Portfolio in Review

As of Q2 2026, Encore Global Management held 74 positions worth $102M, down 29% from $143M the previous quarter. Its ten largest holdings account for 40% of the portfolio.

Encore Global Management withdrew a net $52.7M in Q2 2026, closing 21 positions and reducing 19 holdings. Its most notable exit was Valero Energy, an estimated $4.89M position sold in full.

By sector, the portfolio is most concentrated in Technology at 42% of assets, up from 30% a quarter earlier, followed by Healthcare and Energy.

Against the trend, Encore Global Management opened a new position in CRISPR Therapeutics worth $1.67M.

  • Encore Global Management's largest Q2 2026 buy was CRISPR Therapeutics: 30,557 shares worth $1.67M.
  • Encore Global Management added most to Regeneron Pharmaceuticals in Q2 2026, an estimated $2.69M increase.
  • Encore Global Management's biggest Q2 2026 reduction was Marvell Technology, cutting an estimated $4.75M.
  • Encore Global Management fully exited Valero Energy in Q2 2026, selling an estimated $4.89M.
  • Encore Global Management's ten largest holdings make up 40% of its $102M portfolio in Q2 2026.
  • Encore Global Management opened 4 new positions and closed 21 in Q2 2026.
  • Encore Global Management's portfolio value fell 29% quarter-over-quarter to $102M.

Based on Encore Global Management's 13F filing for Q2 2026, filed 11 Aug 2026.